m.yilmaz
TL2 Moderator · Breda
Contributes reviews on supplier material. Based in Breda.
Joined 20 January 2025 · last posted 7d
89 posts, newest first. Showing up to 150.
-
Submitting a sample: the process end to end Replied, post #98 · Sourcing › Independent verification · 21 Jul 2026 · 19 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #129 · Practice › Reconstitution · 17 Jul 2026 · 0 likes A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly 2.5 mg/mL. The arithmetic is the same; the…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #59 · Outcomes › Body composition · 15 Jul 2026 · 23 likes DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #15 · Start Here › How to Ask · 11 Jul 2026 · 0 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Prescription portability between countries Replied, post #93 · Access › International · 10 Jul 2026 · 1 like Compounding in different countries: some countries allow pharmacy compounding under defined conditions; others do not. The rules are jurisdiction-specific and change.
-
Talking to a therapist about this specifically Replied, post #19 · Wellbeing › Mental health · 7 Jul 2026 · 15 likes When to involve a professional: if mood changes are persistent, deepen over weeks, or interfere with function, involving a mental health professional is appropriate.…
-
CJC-1295 with and without DAC: what the modification does Replied, post #96 · Compounds › Secretagogues & GH axis · 28 Jun 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #76 · Compounds › Repair & healing peptides · 21 Jun 2026 · 0 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Sleep apnoea improving and the equipment implications Replied, post #6 · Wellbeing › Sleep · 15 Jun 2026 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #31 · Compounds › Repair & healing peptides · 13 Jun 2026 · 0 likes Why plausible mechanism is not evidence of effect: a mechanism that is chemically or biologically plausible can fail in practice for dozens of reasons —…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #59 · Practice › Storage & stability · 5 Jun 2026 · 12 likes Beyond-use dating: the date after which a prepared solution should not be used. It is an estimate based on how fast the solution degrades under stated storage, not on…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #19 · Access › Pricing · 30 May 2026 · 25 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #64 · Practice › Storage & stability · 24 May 2026 · 0 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #125 · Devices › Syringes & needles · 16 May 2026 · 16 likes Worth separating two things that post #121 runs together. Needle gauge: smaller numbers (30G) are finer and less painful. Larger numbers (25G) are courser. For…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #116 · Practice › Storage & stability · 15 May 2026 · 28 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Reading a trial's population section before its results Replied, post #14 · Evidence › Trials · 12 May 2026 · 0 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Revisiting: What pooling buys you and what it destroys Replied, post #12 · Evidence › Meta-analyses · 3 May 2026 · 5 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Coming back to: A structured critique template this community uses Replied, post #5 · Evidence › Study critique · 2 May 2026 · 17 likes Defending a paper against criticism: if the authors respond, they might clarify something the paper explained poorly. Their response might also miss your point. Either…
-
Travelling with an injectable: documentation and practicalities Replied, post #24 · Access › International · 29 Apr 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Official shortage notices and what they authorise Replied, post #23 · Access › Shortages · 27 Apr 2026 · 15 likes post #22 answers the question as asked. The question underneath it is different. International supply chains: a shortage in one country does not mean shortage in…
-
A calculator that gives a right answer to the wrong question Replied, post #16 · Data & Tools › Calculators · 19 Apr 2026 · 0 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.
-
List price versus negotiated price versus what you pay Replied, post #32 · Access › Pricing · 10 Apr 2026 · 0 likes Biosimilars and future generics: as patents expire, biosimilar and generic versions might become available and prices might fall. That has already happened for some…
-
Follow-up: State-level differences that actually matter Replied, post #37 · Regional › North America · 6 Apr 2026 · 0 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #89 · Pharmacology › Pharmacokinetics · 31 Mar 2026 · 21 likes post #88 answers the question as asked. The question underneath it is different. Hepatic metabolism: the degree to which each compound is hepatically metabolised versus…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #23 · Meta › Announcements · 30 Mar 2026 · 9 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #28 · Compounds › Tirzepatide · 27 Feb 2026 · 1 like Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #38 · Compounds › Other compounds · 26 Feb 2026 · 1 like On post #34 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #64 · Meta › Site feedback · 6 Feb 2026 · 3 likes Picking up post #61: that is the part I would want checked first. Search and findability: if you searched for something and did not find it, report what you searched…
-
Designing a personal experiment that could change your mind Replied, post #6 · Research Methods › N-of-1 designs · 27 Jan 2026 · 0 likes Worth separating two things that post #2 runs together. Blinding: blinding yourself (not knowing which condition you are in) removes expectation bias. This is hard to…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #36 · Practice › Storage & stability · 23 Jan 2026 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #76 · Practice › Side effects · 20 Jan 2026 · 2 likes I read post #74 twice before replying, because I had assumed the opposite. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back…
-
Aggregates and why a purity assay may miss them entirely Replied, post #68 · Analytics › Impurities & related substances · 12 Jan 2026 · 0 likes Picking up post #65: that is the part I would want checked first. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double…
-
Run-in periods and the population they select Replied, post #49 · Evidence › Trials · 12 Jan 2026 · 0 likes Picking up post #46: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #52 · Practice › Side effects · 8 Jan 2026 · 0 likes Worth separating two things that post #48 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #79 · Compounds › Oral incretins · 28 Dec 2025 · 0 likes post #78 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
The decimal-point error, and the habit that catches it Replied, post #103 · Practice › Reconstitution · 18 Dec 2025 · 13 likes Picking up post #100: that is the part I would want checked first. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are…
-
About the Other compounds category Replied, post #3 · Compounds › Other compounds · 17 Dec 2025 · 1 like As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
-
The decimal-point error, and the habit that catches it Replied, post #78 · Practice › Reconstitution · 17 Dec 2025 · 21 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Personal import allowances, compared — a second dataset Replied, post #37 · Access › International · 17 Dec 2025 · 19 likes Picking up post #34: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Realistic expectations for strength while losing weight quickly Replied, post #42 · Nutrition & Training › Resistance training · 6 Dec 2025 · 22 likes Maintenance is the goal: preserving lean mass and strength during weight loss is the goal of resistance training in this context, not building new muscle. That goal is…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #134 · Practice › Storage & stability · 12 Nov 2025 · 7 likes This follows post #131 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
EMA product information as a primary source Replied, post #25 · Regional › European Union · 2 Nov 2025 · 1 like Italy: AIFA controls reimbursement through a note system. Weight-management indications have not attracted public reimbursement. Regional health authorities add further…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #72 · Analytics › HPLC & UHPLC · 28 Oct 2025 · 27 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #95 · Compounds › Tirzepatide · 23 Oct 2025 · 14 likes Coming back to post #93, because the follow-up matters more than the original answer. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray…
-
MHRA statements, read directly Replied, post #17 · Regional › UK & Ireland · 17 Oct 2025 · 0 likes This follows post #14 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Coverage in the US: a map of the usual obstacles Replied, post #2 · Regional › North America · 15 Oct 2025 · 2 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Liver enzymes drifting down and what that usually means Replied, post #17 · Clinical › Bloodwork · 8 Oct 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #52 · Documentation › Doc review · 5 Sep 2025 · 8 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Journal club: STEP-HFpEF and symptom endpoints Replied, post #8 · Evidence › Journal club · 2 Sep 2025 · 1 like FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
Checking someone else's arithmetic: a worked example thread Replied, post #76 · Practice › Reconstitution · 10 Aug 2025 · 11 likes Coming back to post #74, because the follow-up matters more than the original answer. Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) =…
-
Coming back to: Official shortage notices and what they authorise Replied, post #82 · Access › Shortages · 7 Aug 2025 · 3 likes This follows post #79 rather than contradicting it. Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage.…
-
Temperature loggers worth the money — the long version Replied, post #19 · Devices › Cold chain · 2 Aug 2025 · 19 likes Worth separating two things that post #15 runs together. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque containers reduce light…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #35 · Compounds › Semaglutide · 1 Aug 2025 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. Gastric emptying delay is the mechanism behind most of the gastrointestinal side…
-
How to research a compound with no human data without deceiving yourself Replied, post #14 · Compounds › Other compounds · 30 Jul 2025 · 25 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #74 · Compounds › Repair & healing peptides · 23 Jul 2025 · 0 likes What would change the position on repair peptides: adequately powered, published, peer-reviewed randomised controlled human trials with pre-specified outcomes. That is…
-
Reaching a dose and staying there for a year: a longitudinal note — does this still hold? Replied, post #15 · Practice › Dosing & titration · 22 Jul 2025 · 17 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Tracking that stops updating and then resumes Replied, post #11 · Sourcing › Logistics · 19 Jul 2025 · 0 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
A field-by-field walk through a certificate of analysis Replied, post #40 · Analytics › COA interpretation · 15 Jul 2025 · 26 likes post #39 answers the question as asked. The question underneath it is different. Counter-ion form is crucial: peptides are isolated as salts, most often…
-
Regression to the mean in progress reports Replied, post #26 · Research Methods › Statistics · 29 Jun 2025 · 20 likes Worth separating two things that post #22 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #8 · Compounds › Tirzepatide · 25 Jun 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
"Greater than or equal to 99%" as a specification rather than a result Started this topic · Analytics › COA interpretation · 23 Jun 2025 · 6 likes "Greater than or equal to 99%" as a specification rather than a result Writing it up because I had to work it out twice and would rather nobody else did. Working…
-
Which panel is worth repeating and which is worth ignoring Replied, post #42 · Clinical › Bloodwork · 19 Jun 2025 · 12 likes post #41 answers the question as asked. The question underneath it is different. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Criticising the method without criticising the authors — one year on Replied, post #7 · Evidence › Study critique · 19 Jun 2025 · 3 likes post #6 is right about the mechanism and I think understates the practical bit. When you change your mind: if a reply convinces you that your criticism was not…
-
A report I filed that turned out to be wrong, and the correction Replied, post #105 · Sourcing › Vendor reports · 16 Jun 2025 · 16 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #126 · Data & Tools › Calculators · 10 Jun 2025 · 0 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #8 · Analytics › HPLC & UHPLC · 7 Jun 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and…
-
Pre-registering a personal experiment, seriously Replied, post #11 · Research Methods › N-of-1 designs · 26 May 2025 · 11 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #87 · Sourcing › Red flags · 28 Apr 2025 · 6 likes Picking up post #84: that is the part I would want checked first. Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or…
-
Reading an MS report that only gives you a single number Replied, post #61 · Analytics › Mass spectrometry · 24 Apr 2025 · 16 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
A certificate with no method stated: what can you conclude? Replied, post #23 · Analytics › COA interpretation · 3 Apr 2025 · 5 likes Coming back to post #21, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #3 · Sourcing › Vendor reports · 14 Mar 2025 · 0 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #71 · Access › International · 1 Mar 2025 · 11 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #15 · Analytics › COA interpretation · 21 Feb 2025 · 9 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Individual participant data versus aggregate data Replied, post #19 · Evidence › Meta-analyses · 18 Feb 2025 · 12 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
Distinguishing a deletion sequence by mass alone Replied, post #75 · Analytics › Mass spectrometry · 11 Feb 2025 · 1 like Picking up post #72: that is the part I would want checked first. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #75 · Sourcing › Regulatory · 31 Jan 2025 · 0 likes Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date…
-
Second pass at: Regression to the mean in progress reports Replied, post #38 · Research Methods › Statistics · 29 Jan 2025 · 0 likes On post #34 — agreed on the reasoning, with one qualification. Confounding: a third variable explains an apparent association. In randomised data, randomisation…
-
Transit times by route, from a logged dataset — the long version Replied, post #49 · Sourcing › Logistics · 14 Jan 2025 · 20 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #4 · Compounds › Tirzepatide · 11 Jan 2025 · 1 like Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
Triple agonism: additive, synergistic, or neither? Replied, post #8 · Compounds › Retatrutide · 4 Jan 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #117 · Compounds › Tirzepatide · 29 Dec 2024 · 11 likes On post #113 — agreed on the reasoning, with one qualification. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #6 · Compounds › Secretagogues & GH axis · 27 Dec 2024 · 11 likes Coming back to post #4, because the follow-up matters more than the original answer. Ipamorelin selectivity claims originate in preclinical characterisation and are…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #45 · Compounds › Semaglutide · 21 Dec 2024 · 18 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Reading a supplementary appendix and finding the interesting part Replied, post #40 · Evidence › Trials · 9 Dec 2024 · 0 likes Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than the summary suggests. Where the analysis handled dropouts matters.…
-
Irish differences from the UK position Replied, post #61 · Regional › UK & Ireland · 27 Oct 2024 · 25 likes This follows post #58 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Second pass at: Buffers, pH and why a formulation is a formulation Replied, post #11 · Pharmacology › Formulation chemistry · 22 Oct 2024 · 0 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #24 · Compounds › Semaglutide · 11 Oct 2024 · 7 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #29 · Practice › Interactions · 11 Jul 2024 · 6 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #19 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes Coming back to post #17, because the follow-up matters more than the original answer. The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a…